- Report
- March 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,028GBP
€4339EUR$4,850USD£3,815GBP
- Report
- December 2024
- 55 Pages
Global
From €2236EUR$2,499USD£1,966GBP
- Report
- January 2025
- 50 Pages
Global
From €2236EUR$2,499USD£1,966GBP
- Report
- November 2025
- 262 Pages
Global
From €6258EUR$6,995USD£5,502GBP
- Directory
- November 2025
Global
From €1744EUR$1,950USD£1,534GBP
- Report
- April 2025
- 220 Pages
Global
From €1787EUR$1,997USD£1,571GBP
- Newsletter
- November 2025
Global
€2679EUR$2,995USD£2,356GBP
- Report
- August 2025
- 115 Pages
Global
From €3086EUR$3,450USD£2,714GBP
- Report
- June 2025
- 193 Pages
Global
From €4428EUR$4,950USD£3,893GBP
- Report
- June 2025
- 105 Pages
Global
From €3086EUR$3,450USD£2,714GBP
- Report
- June 2025
- 180 Pages
Global
From €2863EUR$3,200USD£2,517GBP
€3578EUR$4,000USD£3,146GBP
- Report
- February 2025
- 135 Pages
Global
From €3688EUR$4,123USD£3,242GBP
€4339EUR$4,850USD£3,815GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$5,975USD£4,541GBP
- Report
- January 2025
- 142 Pages
Asia Pacific
From €2907EUR$3,250USD£2,556GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4428EUR$4,950USD£3,893GBP
- Report
- September 2025
- 150 Pages
United States
From €5323EUR$5,950USD£4,680GBP
- Report
- November 2024
- 75 Pages
United States
From €3534EUR$3,950USD£3,107GBP
- Report
- August 2025
- 200 Pages
United States
From €2228EUR$2,490USD£1,958GBP
- Report
- September 2025
- 85 Pages
United States
From €3131EUR$3,500USD£2,753GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3578EUR$4,000USD£3,146GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more